West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...
KeyBanc analyst Paul Knight lowered the firm’s price target on West Pharmaceutical (WST) to $325 from $470 to reflect lower FY25 estimates and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback